Loading…
Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhi...
Saved in:
Published in: | Molecules (Basel, Switzerland) Switzerland), 2020-05, Vol.25 (10), p.2356 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3 |
container_end_page | |
container_issue | 10 |
container_start_page | 2356 |
container_title | Molecules (Basel, Switzerland) |
container_volume | 25 |
creator | Oh, Jong Min Rangarajan, T M Chaudhary, Reeta Singh, Rishi Pal Singh, Manjula Singh, Raj Pal Tondo, Anna Rita Gambacorta, Nicola Nicolotti, Orazio Mathew, Bijo Kim, Hoon |
description | Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except
and
, had potent and/or significant selective inhibitory effects on MAO-B.
potently inhibited MAO-B with an IC
value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively.
, and
were also active against MAO-B, both had an IC
value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE.
most potently inhibited MAO-A (IC
= 0.88 µM) and also significantly inhibited MAO-B (IC
= 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor.
and
inhibited AChE with IC
values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of
for MAO-B was higher than that of
(SI = 778.6 vs. 222.2), but the IC
value (0.028 µM) was slightly lower than that of
(0.018 µM). In reversibility experiments, inhibitions of MAO-B by
and
were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K
values of 0.0075 and 0.010 µM, respectively. Our results show that
and
are potent, selective MAO-B inhibitors, and
is a candidate of dual-targeting molecule for MAO-B and AChE. |
doi_str_mv | 10.3390/molecules25102356 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d</doaj_id><sourcerecordid>2405930406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</originalsourceid><addsrcrecordid>eNplkk1v1DAQhiNERUvhB3BBlrhwCfX3JheksiqwUml7gLM1scdNVk5c7KSi_x4vW6oWTrY87zzz4beq3jD6QYiWnowxoF0CZq4Y5ULpZ9URk5zWgsr2-aP7YfUy5y2lnEmmXlSHgksptOJHlb-ItxjIOkDOJHqy7iHYOCG5_DWMSM7mHlMmkMlVnHGaybc4RRiHvcBBxvoTgcmRU4vzXbB9DCWWZ0wlRDZTP3TDHFN-VR14CBlf35_H1Y_PZ9_XX-vzyy-b9el5bWUr5pqxZsU5azrvrGgkKAbSi1YJKZ3qVkxaqXknvW9QILO-0a6zbiUsAGgUXhxXmz3XRdiamzSMkO5MhMH8eYjp2kCaBxvQUO5VwQmLmsuu1PdUK-qk5xY6rl1hfdyzbpZuRGfL-AnCE-jTyDT05jremhVvGsp1Aby_B6T4cylbMeOQLYYAE8YlGy6pFqWoaor03T_SbVzSVFa1U6m2fCLdAdleZVPMOaF_aIZRs3OE-c8RJeft4ykeMv5aQPwGPnO1Mw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405930406</pqid></control><display><type>article</type><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</creator><creatorcontrib>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</creatorcontrib><description>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except
and
, had potent and/or significant selective inhibitory effects on MAO-B.
potently inhibited MAO-B with an IC
value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively.
, and
were also active against MAO-B, both had an IC
value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE.
most potently inhibited MAO-A (IC
= 0.88 µM) and also significantly inhibited MAO-B (IC
= 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor.
and
inhibited AChE with IC
values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of
for MAO-B was higher than that of
(SI = 778.6 vs. 222.2), but the IC
value (0.028 µM) was slightly lower than that of
(0.018 µM). In reversibility experiments, inhibitions of MAO-B by
and
were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K
values of 0.0075 and 0.010 µM, respectively. Our results show that
and
are potent, selective MAO-B inhibitors, and
is a candidate of dual-targeting molecule for MAO-B and AChE.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules25102356</identifier><identifier>PMID: 32443652</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Acetylcholinesterase ; Acetylcholinesterase - chemistry ; Acetylcholinesterase - drug effects ; Amine oxidase (flavin-containing) ; Chalcone - chemistry ; Chalcone - pharmacology ; chalcones ; Cholinesterase Inhibitors - chemistry ; Cholinesterase Inhibitors - isolation & purification ; Cholinesterase Inhibitors - pharmacology ; Drugs ; Ethers ; Ethers - chemistry ; Ethers - pharmacology ; Humans ; Inhibitors ; Kinetics ; monoamine oxidase ; Monoamine Oxidase - chemistry ; Monoamine Oxidase - drug effects ; Monoamine Oxidase Inhibitors - chemistry ; Monoamine Oxidase Inhibitors - isolation & purification ; Monoamine Oxidase Inhibitors - pharmacology ; oximes ; Oximes - chemistry ; Oximes - pharmacology ; Pargyline ; reversibility ; Selectivity</subject><ispartof>Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2356</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</citedby><cites>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</cites><orcidid>0000-0002-5972-1879 ; 0000-0002-7203-3712</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2405930406/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2405930406?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32443652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oh, Jong Min</creatorcontrib><creatorcontrib>Rangarajan, T M</creatorcontrib><creatorcontrib>Chaudhary, Reeta</creatorcontrib><creatorcontrib>Singh, Rishi Pal</creatorcontrib><creatorcontrib>Singh, Manjula</creatorcontrib><creatorcontrib>Singh, Raj Pal</creatorcontrib><creatorcontrib>Tondo, Anna Rita</creatorcontrib><creatorcontrib>Gambacorta, Nicola</creatorcontrib><creatorcontrib>Nicolotti, Orazio</creatorcontrib><creatorcontrib>Mathew, Bijo</creatorcontrib><creatorcontrib>Kim, Hoon</creatorcontrib><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except
and
, had potent and/or significant selective inhibitory effects on MAO-B.
potently inhibited MAO-B with an IC
value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively.
, and
were also active against MAO-B, both had an IC
value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE.
most potently inhibited MAO-A (IC
= 0.88 µM) and also significantly inhibited MAO-B (IC
= 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor.
and
inhibited AChE with IC
values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of
for MAO-B was higher than that of
(SI = 778.6 vs. 222.2), but the IC
value (0.028 µM) was slightly lower than that of
(0.018 µM). In reversibility experiments, inhibitions of MAO-B by
and
were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K
values of 0.0075 and 0.010 µM, respectively. Our results show that
and
are potent, selective MAO-B inhibitors, and
is a candidate of dual-targeting molecule for MAO-B and AChE.</description><subject>Acetylcholinesterase</subject><subject>Acetylcholinesterase - chemistry</subject><subject>Acetylcholinesterase - drug effects</subject><subject>Amine oxidase (flavin-containing)</subject><subject>Chalcone - chemistry</subject><subject>Chalcone - pharmacology</subject><subject>chalcones</subject><subject>Cholinesterase Inhibitors - chemistry</subject><subject>Cholinesterase Inhibitors - isolation & purification</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>Drugs</subject><subject>Ethers</subject><subject>Ethers - chemistry</subject><subject>Ethers - pharmacology</subject><subject>Humans</subject><subject>Inhibitors</subject><subject>Kinetics</subject><subject>monoamine oxidase</subject><subject>Monoamine Oxidase - chemistry</subject><subject>Monoamine Oxidase - drug effects</subject><subject>Monoamine Oxidase Inhibitors - chemistry</subject><subject>Monoamine Oxidase Inhibitors - isolation & purification</subject><subject>Monoamine Oxidase Inhibitors - pharmacology</subject><subject>oximes</subject><subject>Oximes - chemistry</subject><subject>Oximes - pharmacology</subject><subject>Pargyline</subject><subject>reversibility</subject><subject>Selectivity</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplkk1v1DAQhiNERUvhB3BBlrhwCfX3JheksiqwUml7gLM1scdNVk5c7KSi_x4vW6oWTrY87zzz4beq3jD6QYiWnowxoF0CZq4Y5ULpZ9URk5zWgsr2-aP7YfUy5y2lnEmmXlSHgksptOJHlb-ItxjIOkDOJHqy7iHYOCG5_DWMSM7mHlMmkMlVnHGaybc4RRiHvcBBxvoTgcmRU4vzXbB9DCWWZ0wlRDZTP3TDHFN-VR14CBlf35_H1Y_PZ9_XX-vzyy-b9el5bWUr5pqxZsU5azrvrGgkKAbSi1YJKZ3qVkxaqXknvW9QILO-0a6zbiUsAGgUXhxXmz3XRdiamzSMkO5MhMH8eYjp2kCaBxvQUO5VwQmLmsuu1PdUK-qk5xY6rl1hfdyzbpZuRGfL-AnCE-jTyDT05jremhVvGsp1Aby_B6T4cylbMeOQLYYAE8YlGy6pFqWoaor03T_SbVzSVFa1U6m2fCLdAdleZVPMOaF_aIZRs3OE-c8RJeft4ykeMv5aQPwGPnO1Mw</recordid><startdate>20200518</startdate><enddate>20200518</enddate><creator>Oh, Jong Min</creator><creator>Rangarajan, T M</creator><creator>Chaudhary, Reeta</creator><creator>Singh, Rishi Pal</creator><creator>Singh, Manjula</creator><creator>Singh, Raj Pal</creator><creator>Tondo, Anna Rita</creator><creator>Gambacorta, Nicola</creator><creator>Nicolotti, Orazio</creator><creator>Mathew, Bijo</creator><creator>Kim, Hoon</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5972-1879</orcidid><orcidid>https://orcid.org/0000-0002-7203-3712</orcidid></search><sort><creationdate>20200518</creationdate><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><author>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acetylcholinesterase</topic><topic>Acetylcholinesterase - chemistry</topic><topic>Acetylcholinesterase - drug effects</topic><topic>Amine oxidase (flavin-containing)</topic><topic>Chalcone - chemistry</topic><topic>Chalcone - pharmacology</topic><topic>chalcones</topic><topic>Cholinesterase Inhibitors - chemistry</topic><topic>Cholinesterase Inhibitors - isolation & purification</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>Drugs</topic><topic>Ethers</topic><topic>Ethers - chemistry</topic><topic>Ethers - pharmacology</topic><topic>Humans</topic><topic>Inhibitors</topic><topic>Kinetics</topic><topic>monoamine oxidase</topic><topic>Monoamine Oxidase - chemistry</topic><topic>Monoamine Oxidase - drug effects</topic><topic>Monoamine Oxidase Inhibitors - chemistry</topic><topic>Monoamine Oxidase Inhibitors - isolation & purification</topic><topic>Monoamine Oxidase Inhibitors - pharmacology</topic><topic>oximes</topic><topic>Oximes - chemistry</topic><topic>Oximes - pharmacology</topic><topic>Pargyline</topic><topic>reversibility</topic><topic>Selectivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oh, Jong Min</creatorcontrib><creatorcontrib>Rangarajan, T M</creatorcontrib><creatorcontrib>Chaudhary, Reeta</creatorcontrib><creatorcontrib>Singh, Rishi Pal</creatorcontrib><creatorcontrib>Singh, Manjula</creatorcontrib><creatorcontrib>Singh, Raj Pal</creatorcontrib><creatorcontrib>Tondo, Anna Rita</creatorcontrib><creatorcontrib>Gambacorta, Nicola</creatorcontrib><creatorcontrib>Nicolotti, Orazio</creatorcontrib><creatorcontrib>Mathew, Bijo</creatorcontrib><creatorcontrib>Kim, Hoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oh, Jong Min</au><au>Rangarajan, T M</au><au>Chaudhary, Reeta</au><au>Singh, Rishi Pal</au><au>Singh, Manjula</au><au>Singh, Raj Pal</au><au>Tondo, Anna Rita</au><au>Gambacorta, Nicola</au><au>Nicolotti, Orazio</au><au>Mathew, Bijo</au><au>Kim, Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2020-05-18</date><risdate>2020</risdate><volume>25</volume><issue>10</issue><spage>2356</spage><pages>2356-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except
and
, had potent and/or significant selective inhibitory effects on MAO-B.
potently inhibited MAO-B with an IC
value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively.
, and
were also active against MAO-B, both had an IC
value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE.
most potently inhibited MAO-A (IC
= 0.88 µM) and also significantly inhibited MAO-B (IC
= 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor.
and
inhibited AChE with IC
values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of
for MAO-B was higher than that of
(SI = 778.6 vs. 222.2), but the IC
value (0.028 µM) was slightly lower than that of
(0.018 µM). In reversibility experiments, inhibitions of MAO-B by
and
were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K
values of 0.0075 and 0.010 µM, respectively. Our results show that
and
are potent, selective MAO-B inhibitors, and
is a candidate of dual-targeting molecule for MAO-B and AChE.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32443652</pmid><doi>10.3390/molecules25102356</doi><orcidid>https://orcid.org/0000-0002-5972-1879</orcidid><orcidid>https://orcid.org/0000-0002-7203-3712</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1420-3049 |
ispartof | Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2356 |
issn | 1420-3049 1420-3049 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Acetylcholinesterase Acetylcholinesterase - chemistry Acetylcholinesterase - drug effects Amine oxidase (flavin-containing) Chalcone - chemistry Chalcone - pharmacology chalcones Cholinesterase Inhibitors - chemistry Cholinesterase Inhibitors - isolation & purification Cholinesterase Inhibitors - pharmacology Drugs Ethers Ethers - chemistry Ethers - pharmacology Humans Inhibitors Kinetics monoamine oxidase Monoamine Oxidase - chemistry Monoamine Oxidase - drug effects Monoamine Oxidase Inhibitors - chemistry Monoamine Oxidase Inhibitors - isolation & purification Monoamine Oxidase Inhibitors - pharmacology oximes Oximes - chemistry Oximes - pharmacology Pargyline reversibility Selectivity |
title | Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A32%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Class%20of%20Chalcone%20Oxime%20Ethers%20as%20Potent%20Monoamine%20Oxidase-B%20and%20Acetylcholinesterase%20Inhibitors&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Oh,%20Jong%20Min&rft.date=2020-05-18&rft.volume=25&rft.issue=10&rft.spage=2356&rft.pages=2356-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules25102356&rft_dat=%3Cproquest_doaj_%3E2405930406%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2405930406&rft_id=info:pmid/32443652&rfr_iscdi=true |